Rituximab was effective for acute disseminated encephalomyelitis followed by recurrent optic neuritis with anti-myelin oligodendrocyte glycoprotein antibodies

导出原文传递

翻译打印收藏纠错

作者： Nagashima, Masako ^[1] ; Osaka, Hitoshi ^[2] ; Ikeda, Takahiro ^[3] ; Matsumoto, Ayumi ; Miyauchi, Akihiko ; Kaneko, Kimihiko ; Nakashima, Ichiro ; Nakano, Yuko ; Wakabayashi, Kei ; Monden, Yukifumi ; Yamagata, Takanori

作者单位： Tohoku Med & Pharmaceut Univ, Dept Neurol, Sendai, Miyagi, Japan ^[1] Jichi Med Univ, Dept Pediat, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan ^[2] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi, Japan ^[3]

关键词 ADEM ON MOG Rituximab

发布时间 2019-01-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Brain & Development

2018年40卷7期

607-611页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Rituximab was effective for acute disseminated encephalomyelitis followed by recurrent optic neuritis with anti-myelin oligodendrocyte glycoprotein antibodies

Brain & Development

相似文献

Brain & Development

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Rituximab was effective for acute disseminated encephalomyelitis followed by recurrent optic neuritis with anti-myelin oligodendrocyte glycoprotein antibodies

Brain & Development

相似文献

Brain & Development

相关期刊

检索历史清除